Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
EDXC had no cash ($0.00)invested in the Cen Bio deal. EDXC was just waiting to see if they got a license. They didn't so now EDXC still has numerous other M3Hub users in the pipeline.
It's not EDXC partner. If and when Cen got a license, EDXC's M3Hub was going to be used to track it. Many other M3Hub users coming soon. Don't listen to false stories. This will have ZERO effect on EDXC.
Still Not true!
1. The allegations were against Quintek Technologies and Panamed.
2. Todd defended the company, paid for the lawsuit and went to court against the SEC. The case was closed without judgement and a $5,000 dollar fine was paid. The SEC ALWAYS alleges everything hoping for something to stick. Todd was an investor and founder of the science behind Panamed.
3. Todd Davis was not fined nor penalized.
Not true! 1. The allegations were against Quintek Technologies and Panamed.
2. Todd defended the company, paid for the lawsuit and went to court against the SEC. The case was closed without judgement and a $5,000 dollar fine was paid. The SEC ALWAYS alleges everything hoping for something to stick. Todd was an investor and founder of the science behind Panamed.
3. Todd Davis was not fined nor penalized.
Great News! Another piece in the puzzle. More proof that EDXC is the Real Deal!
When I met with Todd Davis in December I saw evidence of all of the items you mentioned. I think the CBD will be huge and will be immediate. The M3Hub will slowly grow as states legalize and will be a monster in the coming years. By the time M3Hub gets rolling EDXC will be $1.00+ just on CBD and AutoSpense. JMHO
EDXC
Looking forward to some good news coming very soon! EDXC
1. The allegations were against Quintek Technologies and Panamed.
2. Todd defended the company, paid for the lawsuit and went to court against the SEC. The case was closed without judgement and a $5,000 dollar fine was paid. The SEC ALWAYS alleges everything hoping for something to stick. Todd was an investor and founder of the science behind Panamed.
3. Todd Davis was not fined nor penalized.
Can't believe we are going to start this BS again.
More industry news written by our CEO Todd Davis. Sure sounds like the person I want steering the ship of my MJ company.
http://stocknewsnow.com/commentary/ANEWSID05012015100004/The-Path-to-Marijuana-Legalization-in-Canada
1. The allegations were against Quintek Technologies and Panamed.
2. Todd defended the company, paid for the lawsuit and went to court against the SEC. The case was closed without judgement and a $5,000 dollar fine was paid. The SEC ALWAYS alleges everything hoping for something to stick. Todd was an investor and founder of the science behind Panamed.
3. Todd Davis was not fined nor penalized.
I've known Todd for 9 years. These are the facts on Panamed:
1. The allegations were against Quintek Technologies and Panamed.
2. Todd defended the company, paid for the lawsuit and went to court against the SEC. The case was closed without judgement and a $5,000 dollar fine was paid. The SEC ALWAYS alleges everything hoping for something to stick. Todd was an investor and founder of the science behind Panamed.
3. Todd Davis was not fined nor penalized.
Great post!!!
Picked up 50k at .0399.
"While in the mean time the competition "EDXC" has theirs installed and working on compliance, while the two zazzz(ERBB) machines have been collecting dust for 8 plus months"
That's funny since 2 weeks ago I read this: "While in the mean time the competition "EDXC" has theirs installed and working on compliance, while the two zazzz(ERBB) machines have been collecting dust for 8 plus months"
Not True. There is no investigation going on for EDXC. Probably ERBB though!!!
Endexx Gears Up to Commercialize Dispensing Technology
Whitefish, MT / ACCESSWIRE / December 17, 2014 / The idea of an automated marijuana-dispensing machine has been a fantasy of sorts since the cannabis industry's inception. By automating the identification, purchasing, and dispensing processes, dispensaries wouldn't have to worry quite as much about critical issues like security, cash management, or proper identification while the device could certainly help cut down on costs over time.
Several companies have already introduced such machines, including MedBox Inc.'s (OTC:MDBX) devices and American Green Inc.'s (OTC:ERBB) ZaZZZ, but the market hasn't been very responsive. After acquiring Autospense-maker Dispense Labs LLC back in 2013, Endexx Corp. (OTC:EDXC) began surveying potential customers instead of simply launching the product into the market and hoping for the best.
Regulatory Clarity
Endexx discovered that many customers were concerned that the machine may not be legal to use in their dispensaries. Working with Vincente Sederberg - a full service law firm focused on the cannabis industry, the company received an opinion letter supporting the legality of such machines. Brian Vincente, a partner in the firm, served as co-director on the Amendment 64 campaign to legalize cannabis in Colorado.
The company's attorneys soon received correspondence back from the State of Colorado Marijuana Enforcement Division stating that installing the machine was legal, but requested an inspection to take a closer look. Some of the areas the M.E.D were interested in were the packaging, labeling, batch tracking and receipt format delivered by the machine. In the upcoming weeks Endexx plans on completing the inspection of the unit to allay any fears or concerns that it may not be fully compliant and transparent for use in the medical and adult-use cannabis industry.
In June, the company announced a 100-day pilot program to test for compliance and tracking integration under Colorado's MED regulations. The program will collect measurable data on dispensary clients' behavior, market test adoption drivers, and collect valuable intelligence on whether the technology improved profitability by offsetting labor costs, improving inventory, and eliminating waiting times.
Improving the Process
The Autospense technology differentiates itself from competitors in many ways, including the use of ID and biometric thumbprints for identification. In addition, the technology includes built-in support for regulatory measures, such as printing receipts with batch numbers and labeling that's required under Colorado law. These attributes help guarantee that dispensaries are meeting and exceeding legal requirements.
In terms of financial improvements, Autospense provides a number of key advantages to dispensaries, including:
- Reduced patient wait-times.
- Automated management of inventory and distribution.
- Ensures the quality of marijuana tested by SC Laboratories.
- Enhances security, accountability, and supply chain management.
- Potential 24/7 sales via machine versus 8 hour per day sales by human.
Looking Ahead
Endexx trades with a market capitalization of about $12 million, which pales in comparison to competitors like MedBox's $162 million and American Green's $52 million market capitalization. Despite its relatively low market cap, the company has made tremendous progress in working with a leading law firm and Colorado's MED in addressing the major client concerns about adoption.
With a pilot program in place at an existing Colorado dispensary, investors can look forward to data that supports the machine's value proposition in the future. The same data could be used to scale its sales into additional dispensaries throughout the state and around the nation over the coming quarters and year. As well, these efforts have the potential to unlock significant value for shareholders over the long-term.
Finally, Autospense only represents one of the company's many projects. Its Cannsumables division - focused on CBDs - recently announced that it would be providing its M3Vape CBD Starter Kit to a voluntary patient study on diabetic neuropathy. These attributes could put Endexx in the same arena as other companies like CannaVEST Corp. (OTC:CANV), which trades with a $100 million market cap.
For more information, visit the company's website at www.endexx.com.
About CannabisFN
Cannabis Financial Network (CannabisFN) is brought to you by TDM Financial, a financial media group and owner of SECFilings.com with over a decade of experience educating investors, profiling public companies, and developing specific investors audiences. CannabisFN is the largest dedicated financial network covering the cannabis and medical marijuana (MMJ) industries and educates investors, business developers and media on industry news, thought leader and executive perspectives, and the fluid regulatory environment while serving as a leading corporate communications platform to public and private companies operating in the industry.
To learn how your company can be covered on CannabisFN, visit http://www.cannabisfn.com/market-defining-companies-program/.
To subscribe to the CannabisFN weekly newsletter or read additional coverage on cannabis laws and investments, visit http://www.cannabisfn.com.
Legal Disclaimer
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.
SOURCE: CannabisFN
http://www.accesswire.com/img.ashx?id=424172
"While in the mean time the competition "EDXC" has theirs installed and working on compliance, while the two zazzz(ERBB) machines have been collecting dust for 8 plus months"
Great post Ty!!
Great post Bushman!!! You are 100% correct on everything!
Great post Mega! Real info for EDXC Shareholders!
While in the mean time the competition "EDXC" has theirs installed and working on compliance, while the two zazzz(ERBB) machines have been collecting dust for 8 plus months"
Endexx Gears Up to Commercialize Dispensing Technology
Whitefish, MT / ACCESSWIRE / December 17, 2014 / The idea of an automated marijuana-dispensing machine has been a fantasy of sorts since the cannabis industry's inception. By automating the identification, purchasing, and dispensing processes, dispensaries wouldn't have to worry quite as much about critical issues like security, cash management, or proper identification while the device could certainly help cut down on costs over time.
Several companies have already introduced such machines, including MedBox Inc.'s (OTC:MDBX) devices and American Green Inc.'s (OTC:ERBB) ZaZZZ, but the market hasn't been very responsive. After acquiring Autospense-maker Dispense Labs LLC back in 2013, Endexx Corp. (OTC:EDXC) began surveying potential customers instead of simply launching the product into the market and hoping for the best.
Regulatory Clarity
Endexx discovered that many customers were concerned that the machine may not be legal to use in their dispensaries. Working with Vincente Sederberg - a full service law firm focused on the cannabis industry, the company received an opinion letter supporting the legality of such machines. Brian Vincente, a partner in the firm, served as co-director on the Amendment 64 campaign to legalize cannabis in Colorado.
The company's attorneys soon received correspondence back from the State of Colorado Marijuana Enforcement Division stating that installing the machine was legal, but requested an inspection to take a closer look. Some of the areas the M.E.D were interested in were the packaging, labeling, batch tracking and receipt format delivered by the machine. In the upcoming weeks Endexx plans on completing the inspection of the unit to allay any fears or concerns that it may not be fully compliant and transparent for use in the medical and adult-use cannabis industry.
In June, the company announced a 100-day pilot program to test for compliance and tracking integration under Colorado's MED regulations. The program will collect measurable data on dispensary clients' behavior, market test adoption drivers, and collect valuable intelligence on whether the technology improved profitability by offsetting labor costs, improving inventory, and eliminating waiting times.
Improving the Process
The Autospense technology differentiates itself from competitors in many ways, including the use of ID and biometric thumbprints for identification. In addition, the technology includes built-in support for regulatory measures, such as printing receipts with batch numbers and labeling that's required under Colorado law. These attributes help guarantee that dispensaries are meeting and exceeding legal requirements.
In terms of financial improvements, Autospense provides a number of key advantages to dispensaries, including:
- Reduced patient wait-times.
- Automated management of inventory and distribution.
- Ensures the quality of marijuana tested by SC Laboratories.
- Enhances security, accountability, and supply chain management.
- Potential 24/7 sales via machine versus 8 hour per day sales by human.
Looking Ahead
Endexx trades with a market capitalization of about $12 million, which pales in comparison to competitors like MedBox's $162 million and American Green's $52 million market capitalization. Despite its relatively low market cap, the company has made tremendous progress in working with a leading law firm and Colorado's MED in addressing the major client concerns about adoption.
With a pilot program in place at an existing Colorado dispensary, investors can look forward to data that supports the machine's value proposition in the future. The same data could be used to scale its sales into additional dispensaries throughout the state and around the nation over the coming quarters and year. As well, these efforts have the potential to unlock significant value for shareholders over the long-term.
Finally, Autospense only represents one of the company's many projects. Its Cannsumables division - focused on CBDs - recently announced that it would be providing its M3Vape CBD Starter Kit to a voluntary patient study on diabetic neuropathy. These attributes could put Endexx in the same arena as other companies like CannaVEST Corp. (OTC:CANV), which trades with a $100 million market cap.
For more information, visit the company's website at www.endexx.com.
About CannabisFN
Cannabis Financial Network (CannabisFN) is brought to you by TDM Financial, a financial media group and owner of SECFilings.com with over a decade of experience educating investors, profiling public companies, and developing specific investors audiences. CannabisFN is the largest dedicated financial network covering the cannabis and medical marijuana (MMJ) industries and educates investors, business developers and media on industry news, thought leader and executive perspectives, and the fluid regulatory environment while serving as a leading corporate communications platform to public and private companies operating in the industry.
To learn how your company can be covered on CannabisFN, visit http://www.cannabisfn.com/market-defining-companies-program/.
To subscribe to the CannabisFN weekly newsletter or read additional coverage on cannabis laws and investments, visit http://www.cannabisfn.com.
Legal Disclaimer
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.
SOURCE: CannabisFN
http://www.accesswire.com/img.ashx?id=424172
"While in the mean time the competition "EDXC" has theirs installed and working on compliance, while the two zazzz(ERBB) machines have been collecting dust for 8 plus months"
Remember this was posted 2 weeks ago by our friend.
"While in the mean time the competition "EDXC" has theirs installed and working on compliance, while the two zazzz machines have been collecting dust for 8 plus months"
Endexx Gears Up to Commercialize Dispensing Technology
Whitefish, MT / ACCESSWIRE / December 17, 2014 / The idea of an automated marijuana-dispensing machine has been a fantasy of sorts since the cannabis industry's inception. By automating the identification, purchasing, and dispensing processes, dispensaries wouldn't have to worry quite as much about critical issues like security, cash management, or proper identification while the device could certainly help cut down on costs over time.
Several companies have already introduced such machines, including MedBox Inc.'s (OTC:MDBX) devices and American Green Inc.'s (OTC:ERBB) ZaZZZ, but the market hasn't been very responsive. After acquiring Autospense-maker Dispense Labs LLC back in 2013, Endexx Corp. (OTC:EDXC) began surveying potential customers instead of simply launching the product into the market and hoping for the best.
Regulatory Clarity
Endexx discovered that many customers were concerned that the machine may not be legal to use in their dispensaries. Working with Vincente Sederberg - a full service law firm focused on the cannabis industry, the company received an opinion letter supporting the legality of such machines. Brian Vincente, a partner in the firm, served as co-director on the Amendment 64 campaign to legalize cannabis in Colorado.
The company's attorneys soon received correspondence back from the State of Colorado Marijuana Enforcement Division stating that installing the machine was legal, but requested an inspection to take a closer look. Some of the areas the M.E.D were interested in were the packaging, labeling, batch tracking and receipt format delivered by the machine. In the upcoming weeks Endexx plans on completing the inspection of the unit to allay any fears or concerns that it may not be fully compliant and transparent for use in the medical and adult-use cannabis industry.
In June, the company announced a 100-day pilot program to test for compliance and tracking integration under Colorado's MED regulations. The program will collect measurable data on dispensary clients' behavior, market test adoption drivers, and collect valuable intelligence on whether the technology improved profitability by offsetting labor costs, improving inventory, and eliminating waiting times.
Improving the Process
The Autospense technology differentiates itself from competitors in many ways, including the use of ID and biometric thumbprints for identification. In addition, the technology includes built-in support for regulatory measures, such as printing receipts with batch numbers and labeling that's required under Colorado law. These attributes help guarantee that dispensaries are meeting and exceeding legal requirements.
In terms of financial improvements, Autospense provides a number of key advantages to dispensaries, including:
- Reduced patient wait-times.
- Automated management of inventory and distribution.
- Ensures the quality of marijuana tested by SC Laboratories.
- Enhances security, accountability, and supply chain management.
- Potential 24/7 sales via machine versus 8 hour per day sales by human.
Looking Ahead
Endexx trades with a market capitalization of about $12 million, which pales in comparison to competitors like MedBox's $162 million and American Green's $52 million market capitalization. Despite its relatively low market cap, the company has made tremendous progress in working with a leading law firm and Colorado's MED in addressing the major client concerns about adoption.
With a pilot program in place at an existing Colorado dispensary, investors can look forward to data that supports the machine's value proposition in the future. The same data could be used to scale its sales into additional dispensaries throughout the state and around the nation over the coming quarters and year. As well, these efforts have the potential to unlock significant value for shareholders over the long-term.
Finally, Autospense only represents one of the company's many projects. Its Cannsumables division - focused on CBDs - recently announced that it would be providing its M3Vape CBD Starter Kit to a voluntary patient study on diabetic neuropathy. These attributes could put Endexx in the same arena as other companies like CannaVEST Corp. (OTC:CANV), which trades with a $100 million market cap.
For more information, visit the company's website at www.endexx.com.
About CannabisFN
Cannabis Financial Network (CannabisFN) is brought to you by TDM Financial, a financial media group and owner of SECFilings.com with over a decade of experience educating investors, profiling public companies, and developing specific investors audiences. CannabisFN is the largest dedicated financial network covering the cannabis and medical marijuana (MMJ) industries and educates investors, business developers and media on industry news, thought leader and executive perspectives, and the fluid regulatory environment while serving as a leading corporate communications platform to public and private companies operating in the industry.
To learn how your company can be covered on CannabisFN, visit http://www.cannabisfn.com/market-defining-companies-program/.
To subscribe to the CannabisFN weekly newsletter or read additional coverage on cannabis laws and investments, visit http://www.cannabisfn.com.
Legal Disclaimer
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.
SOURCE: CannabisFN
http://www.accesswire.com/img.ashx?id=424172
Endexx Gears Up to Commercialize Dispensing Technology
Whitefish, MT / ACCESSWIRE / December 17, 2014 / The idea of an automated marijuana-dispensing machine has been a fantasy of sorts since the cannabis industry's inception. By automating the identification, purchasing, and dispensing processes, dispensaries wouldn't have to worry quite as much about critical issues like security, cash management, or proper identification while the device could certainly help cut down on costs over time.
Several companies have already introduced such machines, including MedBox Inc.'s (OTC:MDBX) devices and American Green Inc.'s (OTC:ERBB) ZaZZZ, but the market hasn't been very responsive. After acquiring Autospense-maker Dispense Labs LLC back in 2013, Endexx Corp. (OTC:EDXC) began surveying potential customers instead of simply launching the product into the market and hoping for the best.
Regulatory Clarity
Endexx discovered that many customers were concerned that the machine may not be legal to use in their dispensaries. Working with Vincente Sederberg - a full service law firm focused on the cannabis industry, the company received an opinion letter supporting the legality of such machines. Brian Vincente, a partner in the firm, served as co-director on the Amendment 64 campaign to legalize cannabis in Colorado.
The company's attorneys soon received correspondence back from the State of Colorado Marijuana Enforcement Division stating that installing the machine was legal, but requested an inspection to take a closer look. Some of the areas the M.E.D were interested in were the packaging, labeling, batch tracking and receipt format delivered by the machine. In the upcoming weeks Endexx plans on completing the inspection of the unit to allay any fears or concerns that it may not be fully compliant and transparent for use in the medical and adult-use cannabis industry.
In June, the company announced a 100-day pilot program to test for compliance and tracking integration under Colorado's MED regulations. The program will collect measurable data on dispensary clients' behavior, market test adoption drivers, and collect valuable intelligence on whether the technology improved profitability by offsetting labor costs, improving inventory, and eliminating waiting times.
Improving the Process
The Autospense technology differentiates itself from competitors in many ways, including the use of ID and biometric thumbprints for identification. In addition, the technology includes built-in support for regulatory measures, such as printing receipts with batch numbers and labeling that's required under Colorado law. These attributes help guarantee that dispensaries are meeting and exceeding legal requirements.
In terms of financial improvements, Autospense provides a number of key advantages to dispensaries, including:
- Reduced patient wait-times.
- Automated management of inventory and distribution.
- Ensures the quality of marijuana tested by SC Laboratories.
- Enhances security, accountability, and supply chain management.
- Potential 24/7 sales via machine versus 8 hour per day sales by human.
Looking Ahead
Endexx trades with a market capitalization of about $12 million, which pales in comparison to competitors like MedBox's $162 million and American Green's $52 million market capitalization. Despite its relatively low market cap, the company has made tremendous progress in working with a leading law firm and Colorado's MED in addressing the major client concerns about adoption.
With a pilot program in place at an existing Colorado dispensary, investors can look forward to data that supports the machine's value proposition in the future. The same data could be used to scale its sales into additional dispensaries throughout the state and around the nation over the coming quarters and year. As well, these efforts have the potential to unlock significant value for shareholders over the long-term.
Finally, Autospense only represents one of the company's many projects. Its Cannsumables division - focused on CBDs - recently announced that it would be providing its M3Vape CBD Starter Kit to a voluntary patient study on diabetic neuropathy. These attributes could put Endexx in the same arena as other companies like CannaVEST Corp. (OTC:CANV), which trades with a $100 million market cap.
For more information, visit the company's website at www.endexx.com.
About CannabisFN
Cannabis Financial Network (CannabisFN) is brought to you by TDM Financial, a financial media group and owner of SECFilings.com with over a decade of experience educating investors, profiling public companies, and developing specific investors audiences. CannabisFN is the largest dedicated financial network covering the cannabis and medical marijuana (MMJ) industries and educates investors, business developers and media on industry news, thought leader and executive perspectives, and the fluid regulatory environment while serving as a leading corporate communications platform to public and private companies operating in the industry.
To learn how your company can be covered on CannabisFN, visit http://www.cannabisfn.com/market-defining-companies-program/.
To subscribe to the CannabisFN weekly newsletter or read additional coverage on cannabis laws and investments, visit http://www.cannabisfn.com.
Legal Disclaimer
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.
SOURCE: CannabisFN
http://www.accesswire.com/img.ashx?id=424172
"While in the mean time the competition "EDXC" has theirs installed and working on compliance, while the two zazzz machines have been collecting dust for 8 plus months"
The Path to Marijuana Legalization in the United States
The Path to Marijuana Legalization is through regulations, traceability, compliance and administrative oversight.
Tuesday, December 16, 2014
By Todd Davis, CEO of Endexx Corp.
Now that Washington D.C., Alaska and Oregon have voted to legalize recreational marijuana, joining the states of Colorado and Washington and the 23 states that have already adopted medical marijuana legislations, the conflict between states and the federal government is once again being highlighted, exposing anomalies and contradictions created by the schedule 1 classification that categorizes marijuana as an illegal substance under federal law and hinders federal funding for research and clinical trials on the medical benefits of cannabis.
In their efforts to remain compliant, legislators and industry participants need to navigate complex challenges and hurdles arising from restrictions on banking, credit card processing, insurance and a provision of the tax code that imposes effective tax rates of 50 to 80 percent.
States and local governments up to now have taken the lead in funding research programs following the momentum shift in popular perception, support and acceptance of cannabis as a viable medical option in treating a wide range of conditions.
In August 2013, following Colorado and Washington states’ adoption of regulations to legalize marijuana for recreational use, the DOJ issued eight guidelines to federal prosecutors in what became known as the Cole Memo on how to handle the distribution of state-regulated marijuana but it failed to provide specific metrics by which state laws could be evaluated, leaving the entire industry vulnerable to federal intervention.
Eric Holder, preparing to step down as Attorney General, stated in September that decriminalization of marijuana at the federal level was for “Congress to decide”. Until Congress acts, the only protection for states’ regulatory agencies is to create and manage traceability systems that strictly meet those guidelines and also to maintain comprehensive administrative oversight over the entire industry and the supply chain in order to create a conducive environment in which business participants have the opportunity to operate without the risk of federal interference and/or of losing the right to be in this burgeoning and lucrative market.
The burden of compliance and enforcement rests now squarely with the states’ regulatory bodies that increasingly rely on the functionality and reliability of their tracking and program management systems to create transparency and full accountability while gathering meaningful data to monitor the efficacy of the program, make necessary improvements and give enforcement personnel the tools to perform their tasks with added efficiency.
While compliance metrics are being formulated state by state and by local jurisdictions to meet federal guidelines through rules and regulations, technology companies have been put to the test to deliver the necessary framework and infrastructure that can help the respective agencies standardize their compliance processes and remain fully adaptive in an ever-changing legal environment.
For Congress to act and the DOJ to adopt a more lenient stance on the classification of cannabis, existing laws will need to go through a fundamental standardization process. This will take time and technology companies providing the tools for compliance to all stakeholders will play a critical role in bridging the regulatory gap and bringing a fragmented market into an integrated, unified and standardized industry.
The right to be a participant in the cannabis industry will come at the cost of compliance. As barriers to entry become more elevated, so do the rewards. License holders have the unique opportunity to make a lot of money, provided that they invest in traceability and compliance. Industry participants and state regulations must collaborate together to set the standards and self regulate. If not, the Federal Government will seize control.
Editor's Note / Todd Davis Bio: Education: Northern Arizona University Bachelor of Science - Administrative Communications. CEO Endexx Corporation 1993-present. Investment Banker/Stock Broker 1990-2000. CEO/Consultant for multiple Small Cap companies 2000-Present. Developer/ Analyst Pro17 market and stock forecast model 2008-Present. As a Broker, Consultant and CEO Todd has participated in and managed/structured over 100 IPO’s, private placements and convertible debentures raising in excess of 100 million in the Small and Micro Cap arena over the last 22 years.
Great article written by EDXC CEO Todd Davis.
EDXC is Great! Todd is Awesome. Shareholders will make Bank! (2nd attempt)
Relaxing at home watching MNF vaping on some fine CBD oil from an awesome EDXC pen. Picked it up a couple weeks ago when I stopped by the EDXC corporate office and saw all kinds of interesting new products. Today's news is just the first step in a major plan which will be unveiled over the coming weeks/months.
I'm comfortable with my 3MM shares. If you want to make money buy EDXC. If not, don't buy EDXC. I don't care. I'll get rich(er) with or without you.
Good luck to all EDXC holders! We will be rewarded.
He's there :)
The name of this company is Endexx Corp EDXC. Try to use it correctly especially if you are posting on other boards.
Just once I'd like to see someone have the Kahunas to admit it was them selling. C'mon sellers....admit it....so I can laugh at you tomorrow.
These dumb a$$ market order sellers are going to be sorry tomorrow!!! :)
Just added 100k to my almost 3 milly. Hmm......
Don't post much here anymore due to the amount of BS. Just wanted to let people know that EDXC has all their ducks in a row and will be going public with the info sooner than later.
NOW is the time to buy. I have been adding and have buyers coming in as I believe this week we begin the move.
Just my opinion.